ClinicalTrials.Veeva

Menu

Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms (3TMR)

Michigan State University logo

Michigan State University

Status

Completed

Conditions

Carotid Plaque Hemorrhage Appearance

Treatments

Other: there is no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT02335567
GE sequence

Details and patient eligibility

About

To compare two competing newly designed 3D sequences for black blood carotid plaque imaging techniques with the industry standard 2D sequnce for black blood.

Full description

To utilize a 3D sequence instead of the usual 2D commonly standard industry sequence that is supplied by the various manufacturers.

Patients with greater than 50% stenosis that are 3T compatible are imaged using the two sequences to compare which sequences better visualize the plaque and it's characteristics

The purpose is to validate the ability of the new 3D sequence to detect and measure any plaque hemorrhage as well as to identify region sof Type 1 hemorrhage.

Enrollment

162 patients

Sex

All

Ages

20 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with 50% stenosis of the carotid arteries that are safe to undergo MRI imaging

Exclusion criteria

  • Patients that are determined to no be safe to undergo MR imaging due to implants

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems